Anteris Technologies (AVR) News Today → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free AVR Stock Alerts Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative April 12, 2024 | finance.yahoo.comThose who invested in Anteris Technologies (ASX:AVR) five years ago are up 292%March 6, 2024 | msn.comASX 200 recoups early losses as major banks push higher, tech stocks pull backMarch 6, 2024 | wsj.comAnteris Technologies Ltd.March 2, 2024 | afr.comAnteris Technologies LtdFebruary 29, 2024 | finance.yahoo.comAnteris Technologies Full Year 2023 Earnings: Misses ExpectationsFebruary 8, 2024 | finance.yahoo.comAnteris Technologies Ltd's (ASX:AVR) largest shareholders are retail investors with 50% ownership, institutions own 29%January 20, 2024 | finance.yahoo.comAnteris Technologies Ltd (AVR.XA)December 19, 2023 | msn.comFDA submission looms as Artrya’s AI platform aims to capture the huge cardio diseases marketNovember 29, 2023 | proactiveinvestors.com.auFDA approval for BiVACOR's artificial heart study paves further paths for heart tech innovationNovember 21, 2023 | morningstar.comAnteris Technologies Ltd AVRNovember 21, 2023 | proactiveinvestors.com.auFIVE at FIVE AU: Mining lifts ASX; RBA minutes suggest further rate hikesNovember 20, 2023 | proactiveinvestors.com.auAnteris Technologies fields "excellent" 30-day haemodynamic...Anteris Technologies fields "excellent" 30-day haemodynamic...November 20, 2023 | proactiveinvestors.comAnteris Technologies fields "excellent" 30-day haemodynamic...October 30, 2023 | proactiveinvestors.comAnteris talks market superiority of its biomimetic TAVR valveOctober 17, 2023 | proactiveinvestors.comAnteris Technologies completes DurAVRTM Early Feasibility Study enrolmentOctober 12, 2023 | proactiveinvestors.com.auFIVE at FIVE AU: ASX slips and US markets stumble on higher-than-expected CPISeptember 12, 2023 | au.investing.comAnteris Technologies to present latest clinical data for DurAVR™September 12, 2023 | finance.yahoo.comAnteris Announces Participation at the Cantor Healthcare Conference on Sept 26th 2023August 14, 2023 | businesswire.comDurAVR™ THV Demonstrates Exceptional Results in Second Valve-in-Valve CaseAugust 9, 2023 | finance.yahoo.comAnteris Technologies Commences US Early Feasibility StudyAugust 9, 2023 | finance.yahoo.comAnteris Technologies Commences American Depository Receipt ProgramAugust 1, 2023 | proactiveinvestors.com.auAnteris welcomes successful DurAVR valve-in-valve procedureJuly 31, 2023 | finance.yahoo.comAnteris Technologies Announces First Successful Implantation of DurAVR™ THV in a Valve-in-Valve ProcedureJuly 30, 2023 | au.investing.comAnteris Technologies’ DurAVR heart valve used in life-saving valve-in-valve procedureJune 14, 2023 | finance.yahoo.comAnteris Technologies says latest first-in-human DurAVR™ results are next-levelJune 10, 2023 | proactiveinvestors.com.auAnteris Technologies presents first-in-human data at conference showing "excellent" haemodynamic performanceMay 31, 2023 | proactiveinvestors.comAnteris Technologies hails "excellent" DurAVR™ THV results in new patient cohortMay 21, 2023 | proactiveinvestors.comAnteris Technologies unveils encouraging FIH results from DurAVR™ heart valve studyMay 16, 2023 | proactiveinvestors.comAnteris Technologies granted additional patent for novel heart valve; shares upApril 27, 2023 | finance.yahoo.comAnteris says new repair device provides another shot on goal for multi-billion dollar productApril 19, 2023 | proactiveinvestors.comAnteris Technologies to diversify portfolio with novel heart valve repair deviceApril 11, 2023 | proactiveinvestors.comAnteris Technologies awarded utility patent for novel transcatheter heart valve replacement technologyApril 4, 2023 | proactiveinvestors.com.auThe smart money in medicine: the world's biggest killerMarch 26, 2023 | proactiveinvestors.comAnteris Technologies receives green light from US FDA to manufacture DurAVR™ Transcatheter Heart ValvesFebruary 16, 2023 | finance.yahoo.comAnteris Technologies CEO talks A$35 million raise and 2023 milestonesFebruary 15, 2023 | finance.yahoo.comAnteris Announces Completion of A$35 Million Capital Raise and Provides 2023 GoalpostsFebruary 15, 2023 | proactiveinvestors.comAnteris Technologies raises A$35 million to fund clinical development of DurAVR™ THV aortic valve technologyFebruary 8, 2023 | au.investing.comAnteris Technologies' transcatheter heart valve continues to demonstrate its potentialFebruary 8, 2023 | proactiveinvestors.comAnteris Technologies receives FDA expanded approval for DurAVR™ EFS; raises $35 millionFebruary 5, 2023 | proactiveinvestors.comAnteris bolsters capital management strategy on commercialisation pathJanuary 16, 2023 | proactiveinvestors.comAnteris Technologies delivers strong 12-month results from DurAVR™ FIH studyDecember 5, 2022 | proactiveinvestors.comAnteris Technologies hails FDA early feasibility study approval for DurAVR™November 28, 2022 | finance.yahoo.comAnteris Technologies Receives FDA Clearance to Initiate Early Feasibility Study for its Novel TAVR Product, DurAVR™November 27, 2022 | proactiveinvestors.comAnteris Technologies higher as DurAVR™ transcatheter heart valve system receives FDA tick for early feasibility studyNovember 27, 2022 | proactiveinvestors.comAnteris Technologies' first in-human study shows restoration of blood flow in patients receiving DurAVR™October 10, 2022 | msn.comDow Futures Move Lower as Earnings Season BeginsOctober 10, 2022 | proactiveinvestors.com.auAnteris Technologies boosted by $1.6 million R&D tax incentive refundSeptember 28, 2022 | proactiveinvestors.com.auAnteris Technologies has valve world talking about 'human-like characteristics' of DurAVRSeptember 19, 2022 | proactiveinvestors.comAnteris Technologies preliminary results show restoration of pre-disease blood flow compared to competing technologiesSeptember 13, 2022 | finance.yahoo.comAnteris Technologies Announces Presentation of First-In-Human Data for its Novel TAVR Product, DurAVR™ at the 2022 Annual TCT Congress in Boston Get Anteris Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for AVR and its competitors with MarketBeat's FREE daily newsletter. Email Address The Only Energy Play You Should Be Looking At (Ad)Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy. Click here to get all the information about it. AVR Media Mentions By Week AVR Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AVR News Sentiment▼0.000.76▲Average Medical News Sentiment AVR News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AVR Articles This Week▼00▲AVR Articles Average Week Get Anteris Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for AVR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: CMXC News Today CHEOF News Today LNDZF News Today GGNDF News Today HTLZF News Today HSCSW News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ASX:AVR) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProShocking: One AI startup's revenue could surge 4,735%Manward PressMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceBill Clinton Backing Biden Replacement???The Freeport SocietyNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anteris Technologies Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
